Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study

被引：21

作者：

Fukuhara, Noriko ^{[1
]}

Yamamoto, Go ^{[2
]}

Tsujimura, Hideki ^{[3
]}

Chou, Takaaki ^{[4
]}

Shibayama, Hirohiko ^{[5
]}

Yanai, Tomoko ^{[6
]}

Shibuya, Kazunori ^{[6
]}

Izutsu, Koji ^{[7
]}

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan

[2] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[3] Chiba Canc Ctr, Div Hematol Oncol, Chiba, Japan

[4] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[5] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka, Japan

[6] Takeda Pharmaceut Co Ltd, Japan Oncol Business Unit, Global Med Affairs Japan, Tokyo, Japan

[7] Natl Canc Ctr, Dept Hematol, Tokyo, Japan

来源：

LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 01期

关键词：

PHASE-II; TRANSPLANTATION; NIVOLUMAB; MULTICOHORT; FAILURE; SGN-35;

D O I：

10.1080/10428194.2019.1654100

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：176 / 180

页数：5

共 14 条

[1] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[2] Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies [J].

Bartlett, Nancy L. ;

Chen, Robert ;

Fanale, Michelle A. ;

Brice, Pauline ;

Gopal, Ajay ;

Smith, Scott E. ;

Advani, Ranjana ;

Matous, Jeffrey V. ;

Ramchandren, Radhakrishnan ;

Rosenblatt, Joseph D. ;

Huebner, Dirk ;

Levine, Pamela ;

Grove, Laurie ;

Forero-Torres, Andres .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7

[3] Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party [J].

Bazarbachi, Ali ;

Boumendil, Ariane ;

Finel, Herve ;

Mohty, Mohamad ;

Castagna, Luca ;

Blaise, Didier ;

Peggs, Karl S. ;

Afanasyev, Boris ;

Diez-Martin, J. L. ;

Corradini, Paolo ;

Michonneau, David ;

Robinson, Stephen ;

Gutierrez Garcia, Gonzalo ;

Bonifazi, Francesca ;

Yakoub-Agha, Ibrahim ;

Gulbas, Zafer ;

Bloor, Adrian ;

Delage, Jeremy ;

Esquirol, Albert ;

Malladi, Ram ;

Scheid, Christof ;

El-Cheikh, Jean ;

Ghesquieres, Herve ;

Montoto, Silvia ;

Dreger, Peter ;

Sureda, Anna .

CANCER, 2019, 125 (01) :90-98

[4] Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers [J].

Carlo-Stella, Carmelo ;

Ricci, Francesca ;

Dalto, Serena ;

Mazza, Rita ;

Malagola, Michele ;

Patriarca, Francesca ;

Viviani, Simonetta ;

Russo, Domenico ;

Giordano, Laura ;

Castagna, Luca ;

Corradini, Paolo ;

Santoro, Armando .

ONCOLOGIST, 2015, 20 (03) :323-328

[5] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].

Chen, Robert ;

Zinzani, Pier Luigi ;

Fanale, Michelle A. ;

Armand, Philippe ;

Johnson, Nathalie A. ;

Brice, Pauline ;

Radford, John ;

Ribrag, Vincent ;

Molin, Daniel ;

Vassilakopoulos, Theodoros P. ;

Tomita, Akihiro ;

von Tresckow, Bastian ;

Shipp, Margaret A. ;

Zhang, Yinghua ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+

[6] Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma [J].

Connors, J. M. ;

Jurczak, W. ;

Straus, D. J. ;

Ansell, S. M. ;

Kim, W. S. ;

Gallamini, A. ;

Younes, A. ;

Alekseev, S. ;

Illes, A. ;

Picardi, M. ;

Lech-Maranda, E. ;

Oki, Y. ;

Feldman, T. ;

Smolewski, P. ;

Savage, K. J. ;

Bartlett, N. L. ;

Walewski, J. ;

Chen, R. ;

Ramchandren, R. ;

Zinzani, P. L. ;

Cunningham, D. ;

Rosta, A. ;

Josephson, N. C. ;

Song, E. ;

Sachs, J. ;

Liu, R. ;

Jolin, H. A. ;

Huebner, D. ;

Radford, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :331-344

[7]

FALINI B, 1995, BLOOD, V85, P1

[8] Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies [J].

Forero-Torres, Andres ;

Bartlett, Nancy L. ;

Berryman, Robert B. ;

Chen, Robert ;

Matous, Jeffrey V. ;

Fanale, Michelle A. ;

O'connor, Owen A. ;

Olshefski, Randal ;

Smith, Scott E. ;

Huebner, Dirk ;

Levine, Pamela L. ;

Grove, Laurie E. ;

Gopal, Ajay K. .

LEUKEMIA & LYMPHOMA, 2015, 56 (04) :1151-1153

[9] Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial [J].

Horwitz, Steven ;

O'Connor, Owen A. ;

Pro, Barbara ;

Illidge, Tim ;

Fanale, Michelle ;

Advani, Ranjana ;

Bartlett, Nancy L. ;

Christensen, Jacob Haaber ;

Morschhauser, Franck ;

Domingo-Domenech, Eva ;

Rossi, Giuseppe ;

Kim, Won Seog ;

Feldman, Tatyana ;

Lennard, Anne ;

Belada, David ;

Illes, Arpad ;

Tobinai, Kensei ;

Tsukasaki, Kunihiro ;

Yeh, Su-Peng ;

Shustov, Andrei ;

Huttmann, Andreas ;

Savage, Kerry J. ;

Yuen, Sam ;

Iyer, Swaminathan ;

Zinzani, Pier Luigi ;

Hua, Zhaowei ;

Little, Meredith ;

Rao, Shangbang ;

Woolery, Joseph ;

Manley, Thomas ;

Trumper, Lorenz ;

Aboulafia, David ;

Alpdogan, Onder ;

Ando, Kiyoshi ;

Arcaini, Luca ;

Baldini, Luca ;

Bellam, Naresh ;

Bartlett, Nancy ;

Ben Yehuda, Dina ;

Benedetti, Fabio ;

Borchman, Peter ;

Bordessoule, Dominique ;

Brice, Pauline ;

Briones, Javier ;

Caballero, Dolores ;

Carella, Angelo Michele ;

Chang, Hung ;

Cheong, June Weon ;

Cho, Seok-Goo ;

Choi, Ilseung .

LANCET, 2019, 393 (10168) :229-240

[10] Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma [J].

Maruyama, Dai ;

Hatake, Kiyohiko ;

Kinoshita, Tomohiro ;

Fukuhara, Noriko ;

Choi, Ilseung ;

Taniwaki, Masafumi ;

Ando, Kiyoshi ;

Terui, Yasuhito ;

Higuchi, Yusuke ;

Onishi, Yasushi ;

Abe, Yasunobu ;

Kobayashi, Tsutomu ;

Shirasugi, Yukari ;

Tobinai, Kensei .

CANCER SCIENCE, 2017, 108 (05) :1007-1012

← 1 2 →